JLLC NatiVita
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Bioequivalence Study of Two Sunitinib Products in Capsules 50 mg in Healthy Volunteers Under Fasting Conditions (NCT05218616) | JLLC NatiVita | 2022-01-21 |
Track JLLC NatiVita automatically
Every clearance here is in the API, with alerts when new ones post.